Back to search
FDAFDA · Food and drugs·Recall number D-0131-2016

TESTOSTERONE, Pellet, 120 mg, Rx only, JD & SN Inc, DBA Moses Lake Professional Pharmacy, 1555 S. Pilgrim St. Moses Lake WA 98837, (509)764-2314

Published November 4, 2015 · Recall initiated: July 24, 2015

Summary

FDA records drug Class II recall D-0131-2016, published November 4, 2015 and initiated July 24, 2015. Recalling firm: JD & SN Inc., dba Moses Lake Professional Pharmacy; Status: Terminated; Reported quantity: 20 pellets; Lot: t12052014@18, t11252014@19, t11192014@18, t11112014@4, t09192014@18, t09102014@20, t08272014@10, t06242015@30, t06022015@8, t05202015@11, t05042015@22, t05012015@17, t04102015@4, t03302015@21, t03202015@18, t03052015@12, t02252015@10, t01302015@23, t01232015@24, t01142015@21. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility; all sterile human compounded drugs within expiry

What to do

Voluntary: Firm initiated · Press Release

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
JD & SN Inc., dba Moses Lake Professional Pharmacy
Distributor
Nationwide
Lot
t12052014@18, t11252014@19, t11192014@18, t11112014@4, t09192014@18, t09102014@20, t08272014@10, t06242015@30, t06022015@8, t05202015@11, t05042015@22, t05012015@17, t04102015@4, t03302015@21, t03202015@18, t03052015@12, t02252015@10, t01302015@23, t01232015@24, t01142015@21.
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was TESTOSTERONE, Pellet, 120 mg, Rx only, JD & SN Inc, DBA Moses Lake Professional Pharmacy, 1555 S. Pilgrim St. Moses Lake WA 98837, (509)764-2314 recalled?

Yes. FDA published recall D-0131-2016 on November 4, 2015. Reported hazard: Lack of Assurance of Sterility; all sterile human compounded drugs within expiry

What should I do if I have this product?

Voluntary: Firm initiated · Press Release